Pacira Short Long Term Debt Total from 2010 to 2024
| PCRX Stock | USD 28.57 0.55 1.89% |
Short and Long Term Debt Total | First Reported 2010-06-30 | Previous Quarter 586 M | Current Value 581.8 M | Quarterly Volatility 275.3 M |
Check Pacira Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 79.4 M, Interest Expense of 16.1 M or Selling General Administrative of 63.1 M, as well as many indicators such as Price To Sales Ratio of 2.19, Dividend Yield of 0.0 or PTB Ratio of 1.7. Pacira financial statements analysis is a perfect complement when working with Pacira Pharmaceuticals Valuation or Volatility modules.
Pacira | Short Long Term Debt Total |
Latest Pacira Pharmaceuticals' Short Long Term Debt Total Growth Pattern
Below is the plot of the Short Long Term Debt Total of Pacira Pharmaceuticals over the last few years. It is Pacira Pharmaceuticals' Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pacira Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Short Long Term Debt Total | 10 Years Trend |
|
Short Long Term Debt Total |
| Timeline |
Pacira Short Long Term Debt Total Regression Statistics
| Arithmetic Mean | 318,891,651 | |
| Geometric Mean | 178,311,123 | |
| Coefficient Of Variation | 99.87 | |
| Mean Deviation | 240,858,648 | |
| Median | 276,497,000 | |
| Standard Deviation | 318,466,560 | |
| Sample Variance | 101420.9T | |
| Range | 1.1B | |
| R-Value | 0.77 | |
| Mean Square Error | 44029.3T | |
| R-Squared | 0.60 | |
| Significance | 0.0007 | |
| Slope | 55,016,619 | |
| Total Sum of Squares | 1419893.3T |
Pacira Short Long Term Debt Total History
About Pacira Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Pacira Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Pacira Pharmaceuticals investors use historical funamental indicators, such as Pacira Pharmaceuticals's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although Pacira Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Pacira Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Pacira Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Pacira Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Pacira Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt Total | 586 M | 348.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| SGC | Superior Uniform Group | |
| VLN | Valens | |
| GNFT | Genfit |
Additional Tools for Pacira Stock Analysis
When running Pacira Pharmaceuticals' price analysis, check to measure Pacira Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira Pharmaceuticals is operating at the current time. Most of Pacira Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pacira Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pacira Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.